AAM seeks clarity, leeway in BA/BE studies guidance
Regulatory NewsFerdous Al-Faruque
GenericsGuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsFerdous Al-FaruqueGenericsGuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)